Lymphocytes and innate immune cells in acute kidney injury and repair.

Al-Jaghbeer, M., Dealmeida, D., Bilderback, A., Ambrosino, R. & Kellum, J. A. Clinical decision support for in-hospital AKI. J. Am. Soc. Nephrol. 29, 654–660 (2018).

pubmed: 29097621 doi: 10.1681/ASN.2017070765

James, M. T., Bhatt, M., Pannu, N. & Tonelli, M. Long-term outcomes of acute kidney injury and strategies for improved care. Nat. Rev. Nephrol. 16, 193–205 (2020).

pubmed: 32051567 doi: 10.1038/s41581-019-0247-z

Ishani, A. et al. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol. 20, 223–228 (2009).

pubmed: 19020007 pmcid: 2615732 doi: 10.1681/ASN.2007080837

Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N. Engl. J. Med. 371, 58–66 (2014).

pubmed: 24988558 pmcid: 9720902 doi: 10.1056/NEJMra1214243

Kellum, J. A. et al. Acute kidney injury. Nat. Rev. Dis. Prim. 7, 52 (2021).

pubmed: 34267223 doi: 10.1038/s41572-021-00284-z

Jang, H. R. & Rabb, H. Immune cells in experimental acute kidney injury. Nat. Rev. Nephrol. 11, 88–101 (2015).

pubmed: 25331787 doi: 10.1038/nrneph.2014.180

Cavaillé-Coll, M. et al. Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am. J. Transpl. 13, 1134–1148 (2013).

doi: 10.1111/ajt.12210

Kurzhagen, J. T., Dellepiane, S., Cantaluppi, V. & Rabb, H. AKI: an increasingly recognized risk factor for CKD development and progression. J. Nephrol. 33, 1171–1187 (2020).

pubmed: 32651850 doi: 10.1007/s40620-020-00793-2

Pefanis, A., Ierino, F. L., Murphy, J. M. & Cowan, P. J. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int. 96, 291–301 (2019).

pubmed: 31005270 doi: 10.1016/j.kint.2019.02.009

Chen, G. Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826–837 (2010).

pubmed: 21088683 pmcid: 3114424 doi: 10.1038/nri2873

Thomas, M. E. et al. The definition of acute kidney injury and its use in practice. Kidney Int. 87, 62–73 (2015).

pubmed: 25317932 doi: 10.1038/ki.2014.328

Kurts, C., Panzer, U., Anders, H. J. & Rees, A. J. The immune system and kidney disease: basic concepts and clinical implications. Nat. Rev. Immunol. 13, 738–753 (2013).

pubmed: 24037418 doi: 10.1038/nri3523

Lee, S. A., Cozzi, M., Bush, E. L. & Rabb, H. Distant organ dysfunction in acute kidney injury: a review. Am. J. Kidney Dis. 72, 846–856 (2018).

pubmed: 29866457 pmcid: 6252108 doi: 10.1053/j.ajkd.2018.03.028

Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384 (2010).

pubmed: 20404851 doi: 10.1038/ni.1863

Anders, H. J. & Schaefer, L. Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J. Am. Soc. Nephrol. 25, 1387–1400 (2014).

pubmed: 24762401 pmcid: 4073442 doi: 10.1681/ASN.2014010117

Anders, H. J., Banas, B. & Schlondorff, D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J. Am. Soc. Nephrol. 15, 854–867 (2004).

pubmed: 15034087 doi: 10.1097/01.ASN.0000121781.89599.16

Wolfs, T. G. et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J. Immunol. 168, 1286–1293 (2002).

pubmed: 11801667 doi: 10.4049/jimmunol.168.3.1286

Leemans, J. C. et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894–2903 (2005).

pubmed: 16167081 pmcid: 1201659 doi: 10.1172/JCI22832

Li, S. et al. Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle/Syk/NF-kappaB signaling. Kidney Int. 104, 305–323 (2023).

pubmed: 37164261 doi: 10.1016/j.kint.2023.04.013

Wu, H. et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847–2859 (2007).

pubmed: 17853945 pmcid: 1974864 doi: 10.1172/JCI31008

Zhang, L. M. et al. Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro. Sci. Rep. 6, 26954 (2016).

pubmed: 27246399 pmcid: 4887891 doi: 10.1038/srep26954

Kulkarni, O. P. et al. Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J. Am. Soc. Nephrol. 25, 978–989 (2014).

pubmed: 24459235 pmcid: 4005301 doi: 10.1681/ASN.2013050528

Andres-Hernando, A. et al. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol. Dial. Transpl. 27, 4339–4347 (2012).

doi: 10.1093/ndt/gfs256

Djudjaj, S. et al. Macrophage migration inhibitory factor limits renal inflammation and fibrosis by counteracting tubular cell cycle arrest. J. Am. Soc. Nephrol. 28, 3590–3604 (2017).

pubmed: 28801314 pmcid: 5698074 doi: 10.1681/ASN.2017020190

Li, J. et al. Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice. Mol. Ther. 26, 2523–2532 (2018).

pubmed: 30077612 pmcid: 6171075 doi: 10.1016/j.ymthe.2018.07.014

Amersfoort, J., Eelen, G. & Carmeliet, P. Immunomodulation by endothelial cells-partnering up with the immune system? Nat. Rev. Immunol. 22, 576–588 (2022).

pubmed: 35288707 pmcid: 8920067 doi: 10.1038/s41577-022-00694-4

Kirita, Y., Wu, H., Uchimura, K., Wilson, P. C. & Humphreys, B. D. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury. Proc. Natl Acad. Sci. USA 117, 15874–15883 (2020).

pubmed: 32571916 pmcid: 7355049 doi: 10.1073/pnas.2005477117

Perry, H. M. et al. Endothelial sphingosine 1phosphate receptor1 mediates protection and recovery from acute kidney injury. J. Am. Soc. Nephrol. 27, 3383–3393 (2016).

pubmed: 26961351 pmcid: 5084889 doi: 10.1681/ASN.2015080922

Privratsky, J. R. et al. A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury. Kidney Int. 103, 514–528 (2023).

pubmed: 36334787 doi: 10.1016/j.kint.2022.10.008

Dumas, S. J. et al. Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation. J. Am. Soc. Nephrol. 31, 118–138 (2020).

pubmed: 31818909 doi: 10.1681/ASN.2019080832

Kalucka, J. et al. Single-cell transcriptome atlas of murine endothelial cells. Cell 180, 764–779.e720 (2020).

pubmed: 32059779 doi: 10.1016/j.cell.2020.01.015

Babickova, J. et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney Int. 91, 70–85 (2017).

pubmed: 27678159 doi: 10.1016/j.kint.2016.07.038

Menshikh, A. et al. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis. Am. J. Physiol. Renal Physiol. 317, F1383–F1397 (2019).

pubmed: 31509009 pmcid: 6879932 doi: 10.1152/ajprenal.00366.2019

Kung, C. W. & Chou, Y. H. Acute kidney disease: an overview of the epidemiology, pathophysiology, and management. Kidney Res. Clin. Pract. 42, 686–699 (2023).

pubmed: 37165615 pmcid: 10698062 doi: 10.23876/j.krcp.23.001

Wang, C., Li, S. W., Zhong, X., Liu, B. C. & Lv, L. L. An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles. Kidney Res. Clin. Pract. 42, 174–187 (2023).

pubmed: 37037480 pmcid: 10085720 doi: 10.23876/j.krcp.22.159

Rabb, H. et al. Inflammation in AKI: current understanding, key questions, and knowledge gaps. J. Am. Soc. Nephrol. 27, 371–379 (2016).

pubmed: 26561643 doi: 10.1681/ASN.2015030261

Ascon, D. B. et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J. Immunol. 177, 3380–3387 (2006).

pubmed: 16920979 doi: 10.4049/jimmunol.177.5.3380

Lai, L. W., Yong, K. C., Igarashi, S. & Lien, Y. H. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int. 71, 1223–1231 (2007).

pubmed: 17377506 doi: 10.1038/sj.ki.5002203

Gharaie Fathabad, S. et al. T lymphocytes in acute kidney injury and repair. Semin. Nephrol. 40, 114–125 (2020).

pubmed: 32303275 doi: 10.1016/j.semnephrol.2020.01.003

Rabb, H. et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 279, F525–F531 (2000).

pubmed: 10966932 doi: 10.1152/ajprenal.2000.279.3.F525

Burne-Taney, M. J. et al. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am. J. Physiol. Renal Physiol. 285, F87–F94 (2003).

pubmed: 12657560 doi: 10.1152/ajprenal.00026.2003

Savransky, V. et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int. 69, 233–238 (2006).

pubmed: 16408111 doi: 10.1038/sj.ki.5000038

Satpute, S. R. et al. The role for T cell repertoire/antigen-specific interactions in experimental kidney ischemia reperfusion injury. J. Immunol. 183, 984–992 (2009).

pubmed: 19561110 doi: 10.4049/jimmunol.0801928

Burne, M. J. et al. Identification of the CD4

pubmed: 11696572 pmcid: 209434 doi: 10.1172/JCI200112080

Liu, M. et al. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J. Am. Soc. Nephrol. 17, 765–774 (2006).

pubmed: 16481417 doi: 10.1681/ASN.2005010102

Abbas, A. K., Murphy, K. M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787–793 (1996).

pubmed: 8893001 doi: 10.1038/383787a0

Bajwa, A. et al. Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J. Immunol. 189, 2584–2596 (2012).

pubmed: 22855711 pmcid: 3433235 doi: 10.4049/jimmunol.1200999

Yokota, N., Burne-Taney, M., Racusen, L. & Rabb, H. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 285, F319–F325 (2003).

pubmed: 12709397 doi: 10.1152/ajprenal.00432.2002

Acosta-Rodriguez, E. V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639–646 (2007).

pubmed: 17486092 doi: 10.1038/ni1467

Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576–587 (2009).

pubmed: 19362022 pmcid: 2705871 doi: 10.1016/j.immuni.2009.02.007

Dong, X., Bachman, L. A., Miller, M. N., Nath, K. A. & Griffin, M. D. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int. 74, 1294–1309 (2008).

pubmed: 18974760 pmcid: 2948974 doi: 10.1038/ki.2008.394

Pindjakova, J. et al. Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction. Kidney Int. 81, 379–390 (2012).

pubmed: 21975862 doi: 10.1038/ki.2011.348

Mehrotra, P., Patel, J. B., Ivancic, C. M., Collett, J. A. & Basile, D. P. Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism. Kidney Int. 88, 776–784 (2015).

pubmed: 26200947 pmcid: 4589446 doi: 10.1038/ki.2015.200

Mehrotra, P., Sturek, M., Neyra, J. A. & Basile, D. P. Calcium channel Orai1 promotes lymphocyte IL-17 expression and progressive kidney injury. J. Clin. Invest. 129, 4951–4961 (2019).

pubmed: 31415242 pmcid: 6819116 doi: 10.1172/JCI126108

Chan, A. J. et al. Innate IL-17A-producing leukocytes promote acute kidney injury via inflammasome and Toll-like receptor activation. Am. J. Pathol. 184, 1411–1418 (2014).

pubmed: 24631024 doi: 10.1016/j.ajpath.2014.01.023

Ascon, D. B. et al. Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J. Leukoc. Biol. 84, 1400–1409 (2008).

pubmed: 18765477 pmcid: 2614602 doi: 10.1189/jlb.0907651

Jang, H. R. et al. Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 297, F1457–F1465 (2009).

pubmed: 19675178 pmcid: 2781336 doi: 10.1152/ajprenal.90769.2008

Stenvinkel, P., Meyer, C. J., Block, G. A., Chertow, G. M. & Shiels, P. G. Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes. Nephrol. Dial. Transpl. 35, 2036–2045 (2020).

doi: 10.1093/ndt/gfz120

Liu, M. et al. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 76, 277–285 (2009).

pubmed: 19436334 doi: 10.1038/ki.2009.157

Noel, S. et al. T lymphocyte-specific activation of Nrf2 protects from AKI. J. Am. Soc. Nephrol. 26, 2989–3000 (2015).

pubmed: 26293820 pmcid: 4657838 doi: 10.1681/ASN.2014100978

Noel, S., Arend, L. J., Bandapalle, S., Reddy, S. P. & Rabb, H. Kidney epithelium specific deletion of kelch-like ECH-associated protein 1 (Keap1) causes hydronephrosis in mice. BMC Nephrol. 17, 110 (2016).

pubmed: 27484495 pmcid: 4969727 doi: 10.1186/s12882-016-0310-y

Suzuki, T. et al. Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus. Nat. Commun. 8, 14577 (2017).

pubmed: 28233855 pmcid: 5333130 doi: 10.1038/ncomms14577

Noel, S., Lee, S. A., Sadasivam, M., Hamad, A. R. A. & Rabb, H. KEAP1 editing using CRISPR/Cas9 for therapeutic NRF2 activation in primary human T lymphocytes. J. Immunol. 200, 1929–1936 (2018).

pubmed: 29352001 doi: 10.4049/jimmunol.1700812

Kurzhagen, J. T. et al. T Cell Nrf2/Keap1 gene editing using CRISPR/Cas9 and experimental kidney ischemia-reperfusion injury. Antioxid. Redox Signal. 38, 959–973 (2023).

pubmed: 36734409 pmcid: 10171956 doi: 10.1089/ars.2022.0058

Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).

pubmed: 12522256 doi: 10.1126/science.1079490

Gandolfo, M. T. et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int. 76, 717–729 (2009).

pubmed: 19625990 doi: 10.1038/ki.2009.259

D’Alessio, F. R., Kurzhagen, J. T. & Rabb, H. Reparative T lymphocytes in organ injury. J. Clin. Invest. 129, 2608–2618 (2019).

pubmed: 31259743 pmcid: 6597230 doi: 10.1172/JCI124614

Kinsey, G. R. et al. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J. Am. Soc. Nephrol. 23, 1528–1537 (2012).

pubmed: 22835488 pmcid: 3431416 doi: 10.1681/ASN.2012010070

Kinsey, G. R. et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J. Am. Soc. Nephrol. 20, 1744–1753 (2009).

pubmed: 19497969 pmcid: 2723989 doi: 10.1681/ASN.2008111160

Lee, H. et al. CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int. 78, 1100–1109 (2010).

pubmed: 20463654 doi: 10.1038/ki.2010.139

Martina, M. N. et al. Double-negative alphabeta T cells are early responders to AKI and are found in human kidney. J. Am. Soc. Nephrol. 27, 1113–1123 (2016).

pubmed: 26315532 doi: 10.1681/ASN.2014121214

Grishkan, I. V., Ntranos, A., Calabresi, P. A. & Gocke, A. R. Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. Cell Immunol. 284, 68–74 (2013).

pubmed: 23933188 pmcid: 3788052 doi: 10.1016/j.cellimm.2013.06.011

Erard, F., Wild, M. T., Garcia-Sanz, J. A. & Le Gros, G. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. Science 260, 1802–1805 (1993).

pubmed: 8511588 doi: 10.1126/science.8511588

Sadasivam, M. et al. Activation and proliferation of PD-1(+) kidney double-negative T cells is dependent on nonclassical MHC proteins and IL-2. J. Am. Soc. Nephrol. 30, 277–292 (2019).

pubmed: 30622155 pmcid: 6362627 doi: 10.1681/ASN.2018080815

Gong, J. et al. TCR

pubmed: 32281417 pmcid: 7311707 doi: 10.1152/ajprenal.00033.2020

Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat. Rev. Immunol. 13, 88–100 (2013).

pubmed: 23348415 pmcid: 3951794 doi: 10.1038/nri3384

Hochegger, K. et al. Role of alpha/beta and gamma/delta T cells in renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 293, F741–F747 (2007).

pubmed: 17567936 doi: 10.1152/ajprenal.00486.2006

Gocze, I. et al. Postoperative cellular stress in the kidney is associated with an early systemic gammadelta T-cell immune cell response. Crit. Care 22, 168 (2018).

pubmed: 29973233 pmcid: 6030780 doi: 10.1186/s13054-018-2094-x

Rossjohn, J., Pellicci, D. G., Patel, O., Gapin, L. & Godfrey, D. I. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12, 845–857 (2012).

pubmed: 23154222 pmcid: 3740582 doi: 10.1038/nri3328

Li, L. et al. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J. Immunol. 178, 5899–5911 (2007).

pubmed: 17442974 doi: 10.4049/jimmunol.178.9.5899

Ferhat, M. et al. Endogenous IL-33 contributes to kidney ischemia-reperfusion Injury as an alarmin. J. Am. Soc. Nephrol. 29, 1272–1288 (2018).

pubmed: 29436517 pmcid: 5875946 doi: 10.1681/ASN.2017060650

Uchida, T. et al. Activated natural killer T cells in mice induce acute kidney injury with hematuria through possibly common mechanisms shared by human CD56

pubmed: 29993279 pmcid: 6172573 doi: 10.1152/ajprenal.00160.2018

Yang, S. H. et al. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J. Am. Soc. Nephrol. 22, 1305–1314 (2011).

pubmed: 21617126 pmcid: 3137578 doi: 10.1681/ASN.2010080815

Shen, P. & Fillatreau, S. Antibody-independent functions of B cells: a focus on cytokines. Nat. Rev. Immunol. 15, 441–451 (2015).

pubmed: 26065586 doi: 10.1038/nri3857

Jang, H. R. et al. B cells limit repair after ischemic acute kidney injury. J. Am. Soc. Nephrol. 21, 654–665 (2010).

pubmed: 20203156 pmcid: 2844308 doi: 10.1681/ASN.2009020182

Burne-Taney, M. J. et al. B cell deficiency confers protection from renal ischemia reperfusion injury. J. Immunol. 171, 3210–3215 (2003).

pubmed: 12960350 doi: 10.4049/jimmunol.171.6.3210

Inaba, A. et al. B lymphocyte-derived CCL7 augments neutrophil and monocyte recruitment, exacerbating acute kidney injury. J. Immunol. 205, 1376–1384 (2020).

pubmed: 32737150 pmcid: 7444279 doi: 10.4049/jimmunol.2000454

Han, H. et al. Renal recruitment of B lymphocytes exacerbates tubulointerstitial fibrosis by promoting monocyte mobilization and infiltration after unilateral ureteral obstruction. J. Pathol. 241, 80–90 (2017).

pubmed: 27763657 doi: 10.1002/path.4831

Burne-Taney, M. J., Yokota-Ikeda, N. & Rabb, H. Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury. Am. J. Transpl. 5, 1186–1193 (2005).

doi: 10.1111/j.1600-6143.2005.00815.x

Peng, B., Ming, Y. & Yang, C. Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation. Cell Death Dis. 9, 109 (2018).

pubmed: 29371592 pmcid: 5833552 doi: 10.1038/s41419-017-0152-y

Ding, Q. et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 121, 3645–3656 (2011).

pubmed: 21821911 pmcid: 3163958 doi: 10.1172/JCI46274

Fang, T. et al. Anti-CD45RB antibody therapy attenuates renal ischemia-reperfusion injury by inducing regulatory B cells. J. Am. Soc. Nephrol. 30, 1870–1885 (2019).

pubmed: 31296607 pmcid: 6779371 doi: 10.1681/ASN.2018101067

Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503–510 (2008).

pubmed: 18425107 doi: 10.1038/ni1582

Zhang, Z. X. et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J. Immunol. 181, 7489–7498 (2008).

pubmed: 19017938 doi: 10.4049/jimmunol.181.11.7489

Victorino, F. et al. Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by anti-asialo-GM1 antibody. J. Immunol. 195, 4973–4985 (2015).

pubmed: 26453755 doi: 10.4049/jimmunol.1500651

Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science 348, aaa6566 (2015).

pubmed: 25999512 pmcid: 5658207 doi: 10.1126/science.aaa6566

Riedel, J. H. et al. IL-33-mediated expansion of type 2 innate lymphoid cells protects from progressive glomerulosclerosis. J. Am. Soc. Nephrol. 28, 2068–2080 (2017).

pubmed: 28154198 pmcid: 5491284 doi: 10.1681/ASN.2016080877

Huang, Q. et al. IL-25 elicits innate lymphoid cells and multipotent progenitor type 2 cells that reduce renal ischemic/reperfusion Injury. J. Am. Soc. Nephrol. 26, 2199–2211 (2015).

pubmed: 25556172 pmcid: 4552110 doi: 10.1681/ASN.2014050479

Cao, Q. et al. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 29, 961–976 (2018).

pubmed: 29295873 pmcid: 5827602 doi: 10.1681/ASN.2017070774

Wang, S. et al. Regulatory innate lymphoid cells control innate intestinal inflammation. Cell 171, 201–216.e218 (2017).

pubmed: 28844693 doi: 10.1016/j.cell.2017.07.027

Cao, Q. et al. Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury. Kidney Int. 97, 130–142 (2020).

pubmed: 31685310 doi: 10.1016/j.kint.2019.07.019

Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).

pubmed: 24115444 pmcid: 4486656 doi: 10.1126/science.1242454

Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570–586 (2017).

pubmed: 28475890 pmcid: 5648021 doi: 10.1016/j.cell.2017.04.004

Patel, C. H., Leone, R. D., Horton, M. R. & Powell, J. D. Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat. Rev. Drug. Discov. 18, 669–688 (2019).

pubmed: 31363227 doi: 10.1038/s41573-019-0032-5

Basso, P. J., Andrade-Oliveira, V. & Camara, N. O. S. Targeting immune cell metabolism in kidney diseases. Nat. Rev. Nephrol. 17, 465–480 (2021).

pubmed: 33828286 doi: 10.1038/s41581-021-00413-7

Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37–46 (2015).

pubmed: 25419705 doi: 10.1038/nm.3762

Lee, K. et al. T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade. JCI Insight 8, e160345 (2023).

pubmed: 37166984 pmcid: 10371253 doi: 10.1172/jci.insight.160345

Burne-Taney, M. J., Yokota, N. & Rabb, H. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int. 67, 1002–1009 (2005).

pubmed: 15698438 doi: 10.1111/j.1523-1755.2005.00163.x

Burne-Taney, M. J. et al. Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease? Am. J. Physiol. Renal Physiol. 291, F981–F986 (2006).

pubmed: 16757731 doi: 10.1152/ajprenal.00229.2005

Ascon, M. et al. Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int. 75, 526–535 (2009).

pubmed: 19092796 doi: 10.1038/ki.2008.602

Ko, G. J. et al. Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5. Am. J. Physiol. Renal Physiol. 302, F762–F773 (2012).

pubmed: 22160774 doi: 10.1152/ajprenal.00335.2011

do Valle Duraes, F. et al. Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight 5, e130651 (2020).

pubmed: 32051345 pmcid: 7098794 doi: 10.1172/jci.insight.130651

Thorenz, A. et al. IL-17A blockade or deficiency does not affect progressive renal fibrosis following renal ischaemia reperfusion injury in mice. J. Pharm. Pharmacol. 69, 1125–1135 (2017).

pubmed: 28573734 doi: 10.1111/jphp.12747

Mehrotra, P. et al. IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats. Am. J. Physiol. Renal Physiol. 312, F385–F397 (2017).

pubmed: 27852609 doi: 10.1152/ajprenal.00462.2016

Dixon, E. E., Wu, H., Muto, Y., Wilson, P. C. & Humphreys, B. D. Spatially resolved transcriptomic analysis of acute kidney injury in a female murine model. J. Am. Soc. Nephrol. 33, 279–289 (2022).

pubmed: 34853151 pmcid: 8819997 doi: 10.1681/ASN.2021081150

Gharaie, S. et al. Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosis. Kidney Int. 104, 470–491 (2023).

pubmed: 37011727 doi: 10.1016/j.kint.2023.03.024

Kim, M. G. et al. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J. Am. Soc. Nephrol. 24, 1529–1536 (2013).

pubmed: 23833258 pmcid: 3785269 doi: 10.1681/ASN.2012080784

Chen, G. et al. mTOR signaling regulates protective activity of transferred CD4+Foxp3+ T cells in repair of acute kidney injury. J. Immunol. 197, 3917–3926 (2016).

pubmed: 27798166 doi: 10.4049/jimmunol.1601251

Gandolfo, M. T. et al. Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl. Immunol. 23, 45–52 (2010).

pubmed: 20412855 pmcid: 5749917 doi: 10.1016/j.trim.2010.04.002

Xia, N. et al. A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial Infarction. Circulation 142, 1956–1973 (2020).

pubmed: 32985264 doi: 10.1161/CIRCULATIONAHA.120.046789

Ito, M. et al. Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature 565, 246–250 (2019).

pubmed: 30602786 doi: 10.1038/s41586-018-0824-5

Juvet, S. C. & Zhang, L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J. Mol. Cell Biol. 4, 48–58 (2012).

pubmed: 22294241 pmcid: 3269300 doi: 10.1093/jmcb/mjr043

Li, H. & Tsokos, G. C. Double-negative T cells in autoimmune diseases. Curr. Opin. Rheumatol. 33, 163–172 (2021).

pubmed: 33394752 pmcid: 8018563 doi: 10.1097/BOR.0000000000000778

Cippa, P. E. et al. A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation. Nat. Commun. 10, 1157 (2019).

pubmed: 30858375 pmcid: 6411919 doi: 10.1038/s41467-019-09092-2

Solez, K., Morel-Maroger, L. & Sraer, J. D. The morphology of “acute tubular necrosis” in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58, 362–376 (1979).

pubmed: 481195 doi: 10.1097/00005792-197909000-00003

Chiao, H. et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99, 1165–1172 (1997).

pubmed: 9077523 pmcid: 507929 doi: 10.1172/JCI119272

Awad, A. S. et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int. 75, 689–698 (2009).

pubmed: 19129795 pmcid: 2656389 doi: 10.1038/ki.2008.648

Melo et al. Integration of spatial and single-cell transcriptomics localizes epithelial cell-immune cross-talk in kidney injury. JCI Insight 6, e147703 (2021).

doi: 10.1172/jci.insight.147703

Winterbourn, C. C., Kettle, A. J. & Hampton, M. B. Reactive oxygen species and neutrophil function. Annu. Rev. Biochem. 85, 765–792 (2016).

pubmed: 27050287 doi: 10.1146/annurev-biochem-060815-014442

Li, L. et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120, 331–342 (2010).

pubmed: 20038794 doi: 10.1172/JCI38702

Block, H. et al. Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury. J. Exp. Med. 209, 407–421 (2012).

pubmed: 22291096 pmcid: 3280874 doi: 10.1084/jem.20111493

Kelly, K. J. et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97, 1056–1063 (1996).

pubmed: 8613529 pmcid: 507153 doi: 10.1172/JCI118498

Rabb, H. et al. Role of Cd11a and Cd11b in ischemic acute-renal-failure in rats. Am. J. Physiol. 267, F1052–F1058 (1994).

pubmed: 7810691

Rouschop, K. M. et al. Protection against renal ischemia reperfusion injury by CD44 disruption. J. Am. Soc. Nephrol. 16, 2034–2043 (2005).

pubmed: 15901765 doi: 10.1681/ASN.2005010054

Tanaka, S. et al. Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia/reperfusion injury. Kidney Int. 92, 154–164 (2017).

pubmed: 28318627 doi: 10.1016/j.kint.2017.01.014

Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134–147 (2018).

pubmed: 28990587 doi: 10.1038/nri.2017.105

Devant, P. & Kagan, J. C. Molecular mechanisms of gasdermin D pore-forming activity. Nat. Immunol. 24, 1064–1075 (2023).

pubmed: 37277654 doi: 10.1038/s41590-023-01526-w

Sanz, A. B., Sanchez-Nino, M. D., Ramos, A. M. & Ortiz, A. Regulated cell death pathways in kidney disease. Nat. Rev. Nephrol. 19, 281–299 (2023).

pubmed: 36959481 pmcid: 10035496 doi: 10.1038/s41581-023-00694-0

Nakazawa, D. et al. Histones and neutrophil extracellular traps enhance tubular necrosis and remote organ injury in ischemic AKI. J. Am. Soc. Nephrol. 28, 1753–1768 (2017).

pubmed: 28073931 pmcid: 5461800 doi: 10.1681/ASN.2016080925

Raup-Konsavage, W. M. et al. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int. 93, 365–374 (2018).

pubmed: 29061334 doi: 10.1016/j.kint.2017.08.014

Rabadi, M., Kim, M., D’Agati, V. & Lee, H. T. Peptidyl arginine deiminase-4-deficient mice are protected against kidney and liver injury after renal ischemia and reperfusion. Am. J. Physiol. Renal Physiol. 311, F437–F449 (2016).

pubmed: 27335376 pmcid: 5008675 doi: 10.1152/ajprenal.00254.2016

Biron, B. M. et al. PAD4 deficiency leads to decreased organ dysfunction and improved survival in a dual insult model of hemorrhagic shock and sepsis. J. Immunol. 200, 1817–1828 (2018).

pubmed: 29374076 doi: 10.4049/jimmunol.1700639

Jansen, M. P. et al. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney Int. 91, 352–364 (2017).

pubmed: 27692564 doi: 10.1016/j.kint.2016.08.006

Deng, B. et al. The leukotriene B4-leukotriene B4 receptor axis promotes cisplatin-induced acute kidney injury by modulating neutrophil recruitment. Kidney Int. 92, 89–100 (2017).

pubmed: 28318626 doi: 10.1016/j.kint.2017.01.009

Melnikov, V. Y. et al. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J. Clin. Invest. 110, 1083–1091 (2002).

pubmed: 12393844 pmcid: 150794 doi: 10.1172/JCI0215623

Tsuji, N. et al. BAM15 treats mouse sepsis and kidney injury, linking mortality, mitochondrial DNA, tubule damage, and neutrophils. J. Clin. Invest. 133, e152401 (2023).

pubmed: 36757801 pmcid: 10065071 doi: 10.1172/JCI152401

Wang, J. et al. Visualizing the function and fate of neutrophils in sterile injury and repair. Science 358, 111–116 (2017).

pubmed: 28983053 doi: 10.1126/science.aam9690

Woodfin, A. et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 12, 761–769 (2011).

pubmed: 21706006 pmcid: 3145149 doi: 10.1038/ni.2062

Garner, H. & de Visser, K. E. Neutrophils take a round-trip. Science 358, 42–43 (2017).

pubmed: 28983037 doi: 10.1126/science.aap8361

Ysebaert, D. K. et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol. Dial. Transpl. 15, 1562–1574 (2000).

doi: 10.1093/ndt/15.10.1562

Lu, L. H. et al. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther. 324, 111–117 (2008).

pubmed: 17932247 doi: 10.1124/jpet.107.130161

Li, L. et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int. 74, 1526–1537 (2008).

pubmed: 18843253 pmcid: 2652647 doi: 10.1038/ki.2008.500

Clements, M. et al. Differential Ly6C expression after renal ischemia-reperfusion identifies unique macrophage populations. J. Am. Soc. Nephrol. 27, 159–170 (2016).

pubmed: 26015452 doi: 10.1681/ASN.2014111138

Anders, H. J. & Ryu, M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 80, 915–925 (2011).

pubmed: 21814171 doi: 10.1038/ki.2011.217

Tang, P. M., Nikolic-Paterson, D. J. & Lan, H. Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat. Rev. Nephrol. 15, 144–158 (2019).

pubmed: 30692665 doi: 10.1038/s41581-019-0110-2

Alikhan, M. A. et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am. J. Pathol. 179, 1243–1256 (2011).

pubmed: 21762674 pmcid: 3157188 doi: 10.1016/j.ajpath.2011.05.037

Lee, S. et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22, 317–326 (2011).

pubmed: 21289217 pmcid: 3029904 doi: 10.1681/ASN.2009060615

Yao, W. et al. Single cell RNA sequencing identifies a unique inflammatory macrophage subset as a druggable target for alleviating acute kidney injury. Adv. Sci. 9, e2103675 (2022).

doi: 10.1002/advs.202103675

Zhang, M. Z. et al. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 122, 4519–4532 (2012).

pubmed: 23143303 pmcid: 3533529 doi: 10.1172/JCI60363

Ferenbach, D. A. et al. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice. Kidney Int. 82, 928–933 (2012).

pubmed: 22673886 doi: 10.1038/ki.2012.207

Jo, S. K., Sung, S. A., Cho, W. Y., Go, K. J. & Kim, H. K. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol. Dial. Transpl. 21, 1231–1239 (2006).

doi: 10.1093/ndt/gfk047

Lee, S. A. et al. Characterization of kidney CD45intCD11bintF4/80+MHCII+CX3CR1+Ly6C- intermediate mononuclear phagocytic cells. PLoS ONE 13, e0198608 (2018).

pubmed: 29856833 pmcid: 5983557 doi: 10.1371/journal.pone.0198608

Shin, N. S. et al. Arginase-1 is required for macrophage-mediated renal tubule regeneration. J. Am. Soc. Nephrol. 33, 1077–1086 (2022).

pubmed: 35577558 pmcid: 9161787 doi: 10.1681/ASN.2021121548

Tseng, W. C., Tsai, M. T., Chen, N. J. & Tarng, D. C. Trichostatin A alleviates renal interstitial fibrosis through modulation of the M2 macrophage subpopulation. Int. J. Mol. Sci. 21, 5966 (2020).

pubmed: 32825118 pmcid: 7503910 doi: 10.3390/ijms21175966

Zhang, M. Z. et al. IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int. 91, 375–386 (2017).

pubmed: 27745702 doi: 10.1016/j.kint.2016.08.020

Sasaki, K. et al. Deletion of myeloid interferon regulatory factor 4 (Irf4) in mouse model protects against kidney fibrosis after ischemic injury by decreased macrophage recruitment and activation. J. Am. Soc. Nephrol. 32, 1037–1052 (2021).

pubmed: 33619052 pmcid: 8259665 doi: 10.1681/ASN.2020071010

Menke, J. et al. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J. Clin. Invest. 119, 2330–2342 (2009).

pubmed: 19587445 pmcid: 2719924 doi: 10.1172/JCI39087

Lin, S. L., Castano, A. P., Nowlin, B. T., Lupher, M. L. Jr. & Duffield, J. S. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J. Immunol. 183, 6733–6743 (2009).

pubmed: 19864592 doi: 10.4049/jimmunol.0901473

Lech, M. et al. Macrophage phenotype controls long-term AKI outcomes–kidney regeneration versus atrophy. J. Am. Soc. Nephrol. 25, 292–304 (2014).

pubmed: 24309188 doi: 10.1681/ASN.2013020152

Kuppe, C. et al. Decoding myofibroblast origins in human kidney fibrosis. Nature 589, 281–286 (2021).

pubmed: 33176333 doi: 10.1038/s41586-020-2941-1

Conway, B. R. et al. Kidney single-cell atlas reveals myeloid heterogeneity in progression and regression of kidney disease. J. Am. Soc. Nephrol. 31, 2833–2854 (2020).

pubmed: 32978267 pmcid: 7790206 doi: 10.1681/ASN.2020060806

Kruger, T. et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15, 613–621 (2004).

pubmed: 14978163 doi: 10.1097/01.ASN.0000114553.36258.91

Kurts, C., Ginhoux, F. & Panzer, U. Kidney dendritic cells: fundamental biology and functional roles in health and disease. Nat. Rev. Nephrol. 16, 391–407 (2020).

pubmed: 32372062 doi: 10.1038/s41581-020-0272-y

Kim, B. S. et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79, 1370–1377 (2005).

pubmed: 15912106 doi: 10.1097/01.TP.0000158355.83327.62

Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. & Mellman, I. Activation of lysosomal function during dendritic cell maturation. Science 299, 1400–1403 (2003).

pubmed: 12610307 doi: 10.1126/science.1080106

Dong, X. et al. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71, 619–628 (2007).

pubmed: 17311071 doi: 10.1038/sj.ki.5002132

Tadagavadi, R. K. & Reeves, W. B. Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells. J. Immunol. 185, 4904–4911 (2010).

pubmed: 20844196 doi: 10.4049/jimmunol.1000383

Tadagavadi, R. K. & Reeves, W. B. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J. Am. Soc. Nephrol. 21, 53–63 (2010).

pubmed: 19875815 pmcid: 2799272 doi: 10.1681/ASN.2009040407

Tittel, A. P. et al. Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat. Methods 9, 385–390 (2012).

pubmed: 22367054 doi: 10.1038/nmeth.1905

Sawitzki, B. et al. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials. Lancet 395, 1627–1639 (2020).

pubmed: 32446407 pmcid: 7613154 doi: 10.1016/S0140-6736(20)30167-7

Li, J. S. Y. et al. Tolerogenic dendritic cells protect against acute kidney injury. Kidney Int. 104, 492–507 (2023).

pubmed: 37244471 doi: 10.1016/j.kint.2023.05.008

Danelli, L. et al. Early phase mast cell activation determines the chronic outcome of renal ischemia-reperfusion injury. J. Immunol. 198, 2374–2382 (2017).

pubmed: 28167630 doi: 10.4049/jimmunol.1601282

Summers, S. A. et al. Mast cells mediate acute kidney injury through the production of TNF. J. Am. Soc. Nephrol. 22, 2226–2236 (2011).

pubmed: 22021718 pmcid: 3279934 doi: 10.1681/ASN.2011020182

Madjene, L. C. et al. Mast cell chymase protects against acute ischemic kidney injury by limiting neutrophil hyperactivation and recruitment. Kidney Int. 97, 516–527 (2020).

pubmed: 31866111 doi: 10.1016/j.kint.2019.08.037

Harding, J. L., Li, Y., Burrows, N. R., Bullard, K. M. & Pavkov, M. E. US trends in hospitalizations for dialysis-requiring acute kidney injury in people with versus without diabetes. Am. J. Kidney Dis. 75, 897–907 (2020).

pubmed: 31843236 doi: 10.1053/j.ajkd.2019.09.012

Hassoun, H. T. et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am. J. Physiol. Renal Physiol. 293, F30–F40 (2007).

pubmed: 17327501 doi: 10.1152/ajprenal.00023.2007

Klein, C. L. et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int. 74, 901–909 (2008).

pubmed: 18596724 doi: 10.1038/ki.2008.314

Ishii, T. et al. Neutrophil elastase contributes to acute lung injury induced by bilateral nephrectomy. Am. J. Pathol. 177, 1665–1673 (2010).

pubmed: 20709801 pmcid: 2947264 doi: 10.2353/ajpath.2010.090793

Lie, M. L. et al. Lung T lymphocyte trafficking and activation during ischemic acute kidney injury. J. Immunol. 189, 2843–2851 (2012).

pubmed: 22888136 doi: 10.4049/jimmunol.1103254

Kramer, A. A. et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int. 55, 2362–2367 (1999).

pubmed: 10354283 doi: 10.1046/j.1523-1755.1999.00460.x

Bernik, T. R. et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781–788 (2002).

pubmed: 11901203 pmcid: 2193742 doi: 10.1084/jem.20011714

Altmann, C. et al. Macrophages mediate lung inflammation in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 302, F421–F432 (2012).

pubmed: 22114207 doi: 10.1152/ajprenal.00559.2010

Teixeira, J. P., Ambruso, S., Griffin, B. R. & Faubel, S. Pulmonary consequences of acute kidney injury. Semin. Nephrol. 39, 3–16 (2019).

pubmed: 30606405 doi: 10.1016/j.semnephrol.2018.10.001

Ahuja, N. et al. Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice. Am. J. Physiol. Renal Physiol. 303, F864–F872 (2012).

pubmed: 22791336 pmcid: 3468527 doi: 10.1152/ajprenal.00025.2012

Andres-Hernando, A. et al. Circulating IL-6 upregulates IL-10 production in splenic CD4(+) T cells and limits acute kidney injury-induced lung inflammation. Kidney Int. 91, 1057–1069 (2017).

pubmed: 28214022 doi: 10.1016/j.kint.2016.12.014

Hoke, T. S. et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J. Am. Soc. Nephrol. 18, 155–164 (2007).

pubmed: 17167117 doi: 10.1681/ASN.2006050494

White, L. E., Santora, R. J., Cui, Y., Moore, F. A. & Hassoun, H. T. TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L449–L459 (2012).

pubmed: 22728466 pmcid: 3468427 doi: 10.1152/ajplung.00301.2011

Doi, K. et al. The high-mobility group protein B1-Toll-like receptor 4 pathway contributes to the acute lung injury induced by bilateral nephrectomy. Kidney Int. 86, 316–326 (2014).

pubmed: 24646859 doi: 10.1038/ki.2014.62

Hepokoski, M. et al. Altered lung metabolism and mitochondrial DAMPs in lung injury due to acute kidney injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 320, L821–L831 (2021).

pubmed: 33565357 pmcid: 8174821 doi: 10.1152/ajplung.00578.2020

Kelly, K. J. Distant effects of experimental renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14, 1549–1558 (2003).

pubmed: 12761255 doi: 10.1097/01.ASN.0000064946.94590.46

Legrand, M. & Rossignol, P. Cardiovascular consequences of acute kidney injury. N. Engl. J. Med. 382, 2238–2247 (2020).

pubmed: 32492305 doi: 10.1056/NEJMra1916393

Ferreira, J. P. et al. Proteomic bioprofiles and mechanistic pathways of progression to heart failure. Circ. Heart Fail. 12, e005897 (2019).

pubmed: 31104495 doi: 10.1161/CIRCHEARTFAILURE.118.005897

Sharp, T. E. 3rd et al. Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system. J. Am. Coll. Cardiol. 72, 2609–2621 (2018).

pubmed: 30466519 doi: 10.1016/j.jacc.2018.08.2186

Polhemus, D. J. et al. Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney. J. Am. Coll. Cardiol. 70, 2139–2153 (2017).

pubmed: 29050562 doi: 10.1016/j.jacc.2017.08.056

Padro, C. J. & Sanders, V. M. Neuroendocrine regulation of inflammation. Semin. Immunol. 26, 357–368 (2014).

pubmed: 24486056 pmcid: 4116469 doi: 10.1016/j.smim.2014.01.003

Crowley, S. D. & Rudemiller, N. P. Immunologic effects of the renin-angiotensin system. J. Am. Soc. Nephrol. 28, 1350–1361 (2017).

pubmed: 28151411 pmcid: 5407736 doi: 10.1681/ASN.2016101066

Rucker, A. J., Rudemiller, N. P. & Crowley, S. D. Salt, hypertension, and immunity. Annu. Rev. Physiol. 80, 283–307 (2018).

pubmed: 29144825 doi: 10.1146/annurev-physiol-021317-121134

Liu, M. et al. Acute kidney injury leads to inflammation and functional changes in the brain. J. Am. Soc. Nephrol. 19, 1360–1370 (2008).

pubmed: 18385426 pmcid: 2440297 doi: 10.1681/ASN.2007080901

Rahati, M., Nozari, M., Eslami, H., Shabani, M. & Basiri, M. Effects of enriched environment on alterations in the prefrontal cortex GFAP- and S100B-immunopositive astrocytes and behavioral deficits in MK-801-treated rats. Neuroscience 326, 105–116 (2016).

pubmed: 27063100 doi: 10.1016/j.neuroscience.2016.03.065

Salama, M. et al. Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol. Disord. Drug Targets 12, 583–586 (2013).

pubmed: 23574173 doi: 10.2174/1871527311312050006

Cao, W. et al. Reno-cerebral reflex activates the renin-angiotensin system, promoting oxidative stress and renal damage after ischemia-reperfusion injury. Antioxid. Redox Signal. 27, 415–432 (2017).

pubmed: 28030955 pmcid: 5549812 doi: 10.1089/ars.2016.6827

Zheng, F. et al. Interleukin-1beta in hypothalamic paraventricular nucleus mediates excitatory renal reflex. Pflug. Arch. 472, 1577–1586 (2020).

doi: 10.1007/s00424-020-02461-7

Zhao, L. et al. Acute kidney injury sensitizes the brain vasculature to ang II (angiotensin II) constriction via FGFBP1 (fibroblast growth factor binding protein 1). Hypertension 76, 1924–1934 (2020).

pubmed: 33040621 doi: 10.1161/HYPERTENSIONAHA.120.15582

Lane, K., Dixon, J. J., MacPhee, I. A. & Philips, B. J. Renohepatic crosstalk: does acute kidney injury cause liver dysfunction? Nephrol. Dial. Transpl. 28, 1634–1647 (2013).

doi: 10.1093/ndt/gft091

Golab, F. et al. Ischemic and non-ischemic acute kidney injury cause hepatic damage. Kidney Int. 75, 783–792 (2009).

pubmed: 19177157 doi: 10.1038/ki.2008.683

Stenvinkel, P. et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly. Kidney Int. 67, 1216–1233 (2005).

pubmed: 15780075 doi: 10.1111/j.1523-1755.2005.00200.x

Gurley, B. J. et al. Extrahepatic ischemia-reperfusion injury reduces hepatic oxidative drug metabolism as determined by serial antipyrine clearance. Pharm. Res. 14, 67–72 (1997).

pubmed: 9034223 doi: 10.1023/A:1012007517877

Park, S. W. et al. Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab. Invest. 91, 63–84 (2011).

pubmed: 20697374 doi: 10.1038/labinvest.2010.151

Park, S. W. et al. Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J. Immunol. 189, 5421–5433 (2012).

pubmed: 23109723 doi: 10.4049/jimmunol.1200581

Gong, J., Noel, S., Pluznick, J. L., Hamad, A. R. A. & Rabb, H. Gut microbiota-kidney cross-talk in acute kidney injury. Semin. Nephrol. 39, 107–116 (2019).

pubmed: 30606403 pmcid: 6322425 doi: 10.1016/j.semnephrol.2018.10.009

Ramezani, A. et al. Role of the gut microbiome in uremia: a potential therapeutic target. Am. J. Kidney Dis. 67, 483–498 (2016).

pubmed: 26590448 doi: 10.1053/j.ajkd.2015.09.027

Noel, S. et al. Gut microbiota-immune system interactions during acute kidney injury. Kidney360 2, 528–531 (2021).

pubmed: 35369013 pmcid: 8785987 doi: 10.34067/KID.0006792020

Osada, Y. et al. Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 321, F455–F465 (2021).

pubmed: 34423680 doi: 10.1152/ajprenal.00111.2021

Andrade-Oliveira, V. et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J. Am. Soc. Nephrol. 26, 1877–1888 (2015).

pubmed: 25589612 pmcid: 4520159 doi: 10.1681/ASN.2014030288

Nakade, Y. et al. Gut microbiota-derived D-serine protects against acute kidney injury. JCI Insight 3, e97957 (2018).

pubmed: 30333299 pmcid: 6237464 doi: 10.1172/jci.insight.97957

Bachem, A. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8

pubmed: 31272808 doi: 10.1016/j.immuni.2019.06.002

Yang, W. & Cong, Y. Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. Cell. Mol. Immunol. 18, 866–877 (2021).

pubmed: 33707689 pmcid: 8115644 doi: 10.1038/s41423-021-00661-4

Jalkanen, S. & Salmi, M. Lymphatic endothelial cells of the lymph node. Nat. Rev. Immunol. 20, 566–578 (2020).

pubmed: 32094869 doi: 10.1038/s41577-020-0281-x

Pei, G. et al. Lymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis. Sci. Adv. 5, eaaw5075 (2019).

pubmed: 31249871 pmcid: 6594767 doi: 10.1126/sciadv.aaw5075

Maarouf, O. H. et al. Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing. JCI Insight 3, e120546 (2018).

pubmed: 29997302 pmcid: 6124521 doi: 10.1172/jci.insight.120546

Zhong, J. et al. Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins. Kidney Int. 100, 585–596 (2021).

pubmed: 34102217 pmcid: 8447488 doi: 10.1016/j.kint.2021.05.028

Lee, S. A. et al. CD4

pubmed: 31889023 doi: 10.4049/jimmunol.1900677

Noel, S. et al. Immune checkpoint molecule TIGIT regulates kidney T cell functions and contributes to AKI. J. Am. Soc. Nephrol. 34, 755–771 (2023).

pubmed: 36747315 pmcid: 10125646 doi: 10.1681/ASN.0000000000000063

Gharaie, S. et al. Single cell and spatial transcriptomics analysis of kidney double negative T lymphocytes in normal and ischemic mouse kidneys. Sci. Rep. 13, 20888 (2023).

pubmed: 38017015 pmcid: 10684868 doi: 10.1038/s41598-023-48213-2

Rabb, H., Lee, K. & Parikh, C. R. Beyond kidney dialysis and transplantation: what’s on the horizon? J. Clin. Invest. 132, e159308 (2022).

pubmed: 35362481 pmcid: 8970661 doi: 10.1172/JCI159308

Lin, N. Y. C. et al. Renal reabsorption in 3D vascularized proximal tubule models. Proc. Natl Acad. Sci. USA 116, 5399–5404 (2019).

pubmed: 30833403 pmcid: 6431199 doi: 10.1073/pnas.1815208116

Petrosyan, A. et al. A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier. Nat. Commun. 10, 3656 (2019).

pubmed: 31409793 pmcid: 6692336 doi: 10.1038/s41467-019-11577-z

Taguchi, A. et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14, 53–67 (2014).

pubmed: 24332837 doi: 10.1016/j.stem.2013.11.010

Takasato, M. et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 16, 118–126 (2014).

pubmed: 24335651 doi: 10.1038/ncb2894

Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193–1200 (2015).

pubmed: 26458176 pmcid: 4747858 doi: 10.1038/nbt.3392

Kroll, K. T. et al. Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies. Proc. Natl Acad. Sci. USA 120, e2305322120 (2023).

pubmed: 37603766 pmcid: 10467620 doi: 10.1073/pnas.2305322120

Lymphocytes and innate immune cells in acute kidney injury and repair.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Kyungho Lee (K)

Hye Ryoun Jang (HR)

Hamid Rabb (H)

Classifications MeSH